Document Type

Article

Publication Date

7-1-2000

Abstract

CSX/NKX2.5 is an evolutionarily conserved homeodomain-containing (HD-containing) transcription factor that is essential for early cardiac development. Recently, ten different heterozygous CSX/NKX2.5 mutations were found in patients with congenital heart defects that are transmitted in an autosomal dominant fashion. To determine the consequence of these mutations, we analyzed nuclear localization, DNA binding, transcriptional activation, and dimerization of mutant CSX/NKX2.5 proteins. All mutant proteins were translated and located to the nucleus, except one splice-donor site mutant whose protein did not accumulate in the cell. All mutants that had truncation or missense mutations in the HD had severely reduced DNA binding activity and little or no transcriptional activation function. In contrast, mutants with intact HDs exhibit normal DNA binding to the monomeric binding site but had three- to ninefold reduction in DNA binding to the dimeric binding sites. HD missense mutations that preserved homodimerization ability inhibited the activation of atrial natriuretic factor by wild-type CSX/NKX2.5. Although our studies do not characterize the genotype-phenotype relationship of the ten human mutations, they identify specific abnormalities of CSX/NKX2.5 function essential for transactivation of target genes.

Comments

Article written by researchers from Cardiovascular Division, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School;Department of Genetics, Harvard Medical School;Howard Hughes Medical Institute;Division of Pediatric Cardiology, Medical University of South Carolina;and Cardiovascular Division, Brigham and Women's Hospital. Published in the Journal of Clinical Investigation, July 2000, volume 106, number 2, pages 299-308. Includes abstract, references, and diagrams.

Download

Share

COinS